×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TVRD – tvardi therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TVRD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/13
06:02 am
tvrd
Tvardi Therapeutics (TVRD) had its "sell (e+)" rating reaffirmed by Weiss Ratings.
Medium
Report
Tvardi Therapeutics (TVRD) had its "sell (e+)" rating reaffirmed by Weiss Ratings.
4/3
07:22 am
tvrd
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium [Yahoo! Finance]
Low
Report
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium [Yahoo! Finance]
4/2
08:01 am
tvrd
Tvardi Therapeutics (TVRD) had its "buy" rating reaffirmed by BTIG Research. They now have a $15.00 price target on the stock.
Low
Report
Tvardi Therapeutics (TVRD) had its "buy" rating reaffirmed by BTIG Research. They now have a $15.00 price target on the stock.
4/2
08:00 am
tvrd
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
Low
Report
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
4/1
03:15 pm
tvrd
Tvardi Therapeutics (TVRD) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "equal weight" rating on the stock.
Medium
Report
Tvardi Therapeutics (TVRD) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "equal weight" rating on the stock.
4/1
02:11 pm
tvrd
Tvardi Therapeutics (TVRD) had its price target lowered by Piper Sandler from $4.00 to $3.00. They now have a "neutral" rating on the stock.
Medium
Report
Tvardi Therapeutics (TVRD) had its price target lowered by Piper Sandler from $4.00 to $3.00. They now have a "neutral" rating on the stock.
3/31
04:34 pm
tvrd
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update [Yahoo! Finance]
Low
Report
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update [Yahoo! Finance]
3/31
04:01 pm
tvrd
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Medium
Report
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Date
Time
Symbol
Company Name
Action
%Chg
3/31/2026
04:01 pm
tvrd
tvardi therapeutics, inc.
MISS
Report
-5.7%
tvardi therapeutics, inc.
11/13/2025
04:01 pm
tvrd
tvardi therapeutics, inc.
BEAT
Report
-1.9%
tvardi therapeutics, inc.
Date
Time
Symbol
Headline
Impact
4/1
06:08 am
tvrd
Form POS EX Tvardi Therapeutics,
Low
Report
Form POS EX Tvardi Therapeutics,
3/31
04:11 pm
tvrd
Form 10-K Tvardi Therapeutics, For: Dec 31
Medium
Report
Form 10-K Tvardi Therapeutics, For: Dec 31
3/31
04:09 pm
tvrd
Form 8-K Tvardi Therapeutics, For: Mar 31
Medium
Report
Form 8-K Tvardi Therapeutics, For: Mar 31
3/6
04:01 pm
tvrd
Form 8-K Tvardi Therapeutics, For: Mar 06
Low
Report
Form 8-K Tvardi Therapeutics, For: Mar 06
2/17
05:30 pm
tvrd
Form SCHEDULE 13G/A Tvardi Therapeutics, Filed by: DePinho Ronald A
Low
Report
Form SCHEDULE 13G/A Tvardi Therapeutics, Filed by: DePinho Ronald A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: